单细胞RNA测序鉴定骨髓瘤性积液的进化机制
本研究对3例骨髓瘤性积液患者的骨髓、外周血和胸水/腹水进行单细胞RNA测序分析,发现积液含更高比例的细胞毒性T细胞而外周血含更高比例初始T细胞,鉴定出在髓内和髓外浆细胞群高表达的基因模块并定义为髓外起始细胞,LILRB4在髓外髓外起始细胞中上调并体外证实促进骨髓瘤细胞迁移。
要点
- 骨髓瘤性积液含更高比例细胞毒性T细胞,外周血含更高比例初始T细胞。
- 髓外起始细胞高表达与增殖增加、p53信号及骨髓瘤不良预后相关的基因模块。
- LILRB4在髓外髓外起始细胞中上调,体外证实促进骨髓瘤细胞迁移。
核心结论
- 本研究为骨髓瘤性积液的进化机制提供了见解,并定义了与髓外发展相关的髓外起始细胞和LILRB4。
研究设计与样本
- 对3例骨髓瘤性积液患者的骨髓、外周血和胸水/腹水样本进行单细胞RNA测序转录组分析。
主要发现
- 骨髓瘤性积液含更高比例的细胞毒性T细胞,外周血含更高比例的初始T细胞。
- 恶性细胞在表达特征上存在位点内和位点间及患者间差异。
- 鉴定出在髓内和髓外浆细胞群高表达的基因模块,并将表达该基因集的细胞群定义为髓外起始细胞。
- 该基因集与细胞增殖增加相关,参与p53信号,并与骨髓瘤不良预后相关。
- 转录调节因子E2F1、YY1和SMAD1在髓外起始细胞中活化。
关键数值与推荐
- 白细胞免疫球蛋白样受体亚家族B4(LILRB4)在髓外髓外起始细胞中上调。
- 体外证实LILRB4促进骨髓瘤细胞迁移。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Myelomatous effusion (ME) is a rare manifestation of extramedullary multiple myeloma (MM) with limited therapeutic options and poor outcomes. The molecular mechanisms underlying ME are incompletely understood. We profiled transcriptomes of bone marrow, peripheral blood (PB), and pleural effusion/ascites from 3 patients with ME using single-cell RNA sequencing analysis. We found that ME contained a higher percentage of cytotoxic T cells, whereas PB contained a higher proportion of naive T cells. Malignant cells varied within and between sites and patients in their expression of signatures. We identified a gene module highly expressed in intramedullary and extramedullary plasma cell clusters and defined cell clusters expressing this gene set as extramedullary-initiating cells (EMICs). This gene set was associated with increased cellular proliferation, involved in p53 signaling, and related to poor prognosis in MM. The transcriptional regulators E2F1, YY1, and SMAD1 were activated in EMICs. Leukocyte immunoglobulin-like receptor subfamily B4 (LILRB4) was upregulated in extramedullary EMICs. We confirmed that LILRB4 promoted MM cell migration in vitro. This study provided insight into the evolutionary mechanisms of ME and defined EMICs and LILRB4 associated with extramedullary development.
引用
- Sun Z, Ji J, Li Y, et al. Identification of evolutionary mechanisms of myelomatous effusion by single-cell RNA sequencing. Blood Adv. 2023. PMID: 37276129. doi:10.1182/bloodadvances.2022009477
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。